Skip to content

Investigating the role of rTMS in the treatment of chronic depression

Investigating the role of rTMS in the treatment of chronic depression - rTMS in depression

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43899
Enrollment
100
Registered
2013-03-14
Start date
2013-12-02
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression major depressive disorder

Interventions

Obermann et al., 2011). Firstly, the resting motor threshold (rMT) will be defined in each subject as the minimal stimulation intensity evoking an MEP of >= 0.05 mV in 50% of the trials in the musc

Sponsors

Psychiatrie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Males and females above 18 years of age • First or recurrent unipolar major depressive disorder without psychotic symptoms (DSM-IV), with a chronic course during the last two years • Treatment resistance for at least two antidepressants treatment and a form of psychotherapy.

Exclusion criteria

Exclusion criteria: Presence of a current or past relevant somatic or neurological disorder A comorbid diagnosis of bipolar disorder, schizophrenia or substance dependence disorders.;With regard to transcranial brain stimulation • Epilepsy, convulsion or seizure (TMS) • Serious head trauma or brain surgery • Large or ferromagnetic metal parts in the head (except for a dental wire) • Implanted cardiac pacemaker or neurostimulator • Pregnancy With regard to other experimental techniques MRI-related exclusion criteria like claustrophobia, metal in body, pacemaker, pregnancy, etc.

Design outcomes

Primary

MeasureTime frame
Primary endpoint is the change in depressive symptoms between both groups after rTMS treatment.

Secondary

MeasureTime frame
Secondary endpoint is the change in depressive symptoms after 5 weeks and routine -outcome monitoring (ROM) parameters.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)